fbpx

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.
research cancer

Apatinib Shows Promising Survival Advantage in Advanced Gastric Cancer

Apatinib demonstrated an improvement in overall survival (OS) by 1.8 months and an acceptable toxicity profile compared to placebo as treatment for advanced gastric cancer, according to findings published in the Journal of Clinical Oncology.

Read Source
Please join with us to fuel the next wave of progress.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.
Please join with us to fuel the next wave of progress. Support our 2024 Fundraising Campaign.

Your support today will honor the memories of those we have lost and create much-needed hope for those who are bravely facing the disease today. Contributions are tax-deductible.

Together, we will defeat stomach cancer.

Together, we will defeat stomach cancer.

MORE INFODONATE
X